Hepatitis B virus antigens — Drug Target

All drugs that target Hepatitis B virus antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Therapeutic vaccine

Phase 3 pipeline (1)

• Hepavax-Gene · Chiang Mai University · Therapeutic vaccine · Virology / Infectious Disease
  Hepavax-Gene is a therapeutic hepatitis B vaccine designed to generate immune responses against hepatitis B virus through genetic engineering approaches.